TCL Archive Fidaxomicin for CDI Therapy More Cost-Effective Than Vancomycin, Study Says September 26, 2014
TCL Archive Also in this 12-page issue: GM Cancer Research Foundation awards annual prizes to four scientists. June 4, 2004
TCL Archive Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34% June 28, 2013